Sigilon Therapeutics, Inc. Stock
Equities
SGTX
US82657L2060
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Director of Finance/CFO | 58 | 19-10-31 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 18-08-13 | |
Philip Johnson
PSD | President | 59 | 23-08-10 |
Gordon Brooks
BRD | Director/Board Member | - | 23-08-10 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+12.24% | 42.74B | |
+43.12% | 41.36B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |